We are live on ! Find out more
TCIM

TIAA CREF Investment Management Portfolio holdings

AUM $141B
1-Year Est. Return 14.18%
This Fund
S&P 500
This Quarter Est. Return
+16.04%
1 Year Est. Return
+14.18%
3 Year Est. Return
+70.07%
5 Year Est. Return
+108.37%
10 Year Est. Return
AUM
$141B
AUM Growth
+$15B
Cap. Flow
-$3.33B
Cap. Flow %
-2.36%
Top 10 Hldgs %
20.05%
Holding
3,067
New
60
Increased
1,132
Reduced
1,578
Closed
64

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$493M
2
MSFT icon
Microsoft
MSFT
+$336M
3
NOC icon
Northrop Grumman
NOC
+$224M
4
NVDA icon
NVIDIA
NVDA
+$208M
5
MAR icon
Marriott International
MAR
+$202M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Financials 14.22%
3 Healthcare 13.74%
4 Consumer Discretionary 11.39%
5 Communication Services 10.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRS
2926
DELISTED
Amyris Inc.
AMRS
$127K ﹤0.01%
60,606
ROX
2927
DELISTED
Castle Brands, Inc.
ROX
$127K ﹤0.01%
182,323
NTP
2928
DELISTED
Nam Tai Property Inc.
NTP
$127K ﹤0.01%
12,925
-2,740
-17% -$25K
MGI
2929
DELISTED
MoneyGram International, Inc. New
MGI
$126K ﹤0.01%
61,611
-42,819
-41% -$97.7K
CWBR
2930
DELISTED
CohBar, Inc. Common Stock
CWBR
$125K ﹤0.01%
1,277
+43
+3% +$4.34K
MBIO icon
2931
Mustang Bio
MBIO
$4.39M
$124K ﹤0.01%
49
+23
+88% +$65.1K
COGT icon
2932
Cogent Biosciences
COGT
$6.76B
$122K ﹤0.01%
6,945
+988
+17% +$16.9K
LEGH icon
2933
Legacy Housing
LEGH
$629M
$122K ﹤0.01%
+10,291
New +$137K
SIEB icon
2934
Siebert Financial
SIEB
$65.9M
$121K ﹤0.01%
10,249
-51
-0.5% -$628
SER icon
2935
Serina Therapeutics
SER
$31M
$120K ﹤0.01%
845
HOV icon
2936
Hovnanian Enterprises
HOV
$779M
$116K ﹤0.01%
10,605
-1
-0% -$16
ALNA
2937
DELISTED
Allena Pharmaceuticals
ALNA
$114K ﹤0.01%
16,211
-45
-0.3% -$326
OPBK icon
2938
OP Bancorp
OPBK
$235M
$113K ﹤0.01%
12,867
-30
-0.2% -$273
AREX
2939
DELISTED
Approach Resources Inc.
AREX
$110K ﹤0.01%
310,907
+4,547
+1% +$4.27K
KG
2940
Kestrel Group
KG
$66.1M
$109K ﹤0.01%
7,352
+180
+3% +$4.16K
LUMO
2941
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$109K ﹤0.01%
6,296
+3
+0% +$45
APTX
2942
DELISTED
Aptinyx Inc. Common Stock
APTX
$108K ﹤0.01%
26,748
CTIC
2943
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$106K ﹤0.01%
109,634
+3,966
+4% +$4.18K
KODK icon
2944
Kodak
KODK
$809M
$105K ﹤0.01%
35,552
+24
+0.1% +$73
METC icon
2945
Ramaco Resources Class A
METC
$629M
$103K ﹤0.01%
+18,351
New +$99.9K
VUZI icon
2946
Vuzix
VUZI
$178M
$103K ﹤0.01%
33,564
TLGT
2947
DELISTED
Teligent, Inc
TLGT
$103K ﹤0.01%
8,918
-12
-0.1% -$181
NCSM icon
2948
NCS Multistage Holdings
NCSM
$116M
$101K ﹤0.01%
971
ADMA icon
2949
ADMA Biologics
ADMA
$2.02B
$100K ﹤0.01%
26,291
LLEX
2950
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$100K ﹤0.01%
85,388
+68
+0.1% +$117

Similar funds

TIAA CREF Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, TIAA CREF Investment Management held 3,067 positions worth $141B, up 12% from $126B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 4%. TIAA CREF Investment Management opened 60 new positions and exited 64, leaving the 3,067-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • TIAA CREF Investment Management's largest Q1 2019 buy was Takeda Pharmaceutical: 6,555,742 shares worth $134M.
  • TIAA CREF Investment Management added most to Meta Platforms (Facebook) in Q1 2019, an estimated $253M increase.
  • TIAA CREF Investment Management's biggest Q1 2019 reduction was JPMorgan Chase, cutting an estimated $493M.
  • TIAA CREF Investment Management fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $165M.
  • TIAA CREF Investment Management's ten largest holdings make up 20% of its $141B portfolio in Q1 2019.
  • TIAA CREF Investment Management opened 60 new positions and closed 64 in Q1 2019.
  • TIAA CREF Investment Management's portfolio value rose 12% quarter-over-quarter to $141B.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.